Evidence map›Paper›PMID 40160300›Full record

ArticleMolecular and clinical oncology2025

Treatment strategy for maxillary gingival metastasis arising from gastric adenocarcinoma: A case report and literature review.

Hitoshi Miyashita, Masaki Sugazaki, Haruka Saito, Chieko Kudo, Munenori Nagao, Yojiro Ishikawa, Satoshi Teramura, Fumiaki Shinohara, Kazuhiro Murakami

Abstract readCase Reports
In one paragraph

Article in Molecular and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hitoshi MiyashitaDepartment of Dentistry and Oral Surgery, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Masaki SugazakiDepartment of Dentistry and Oral Surgery, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Haruka SaitoDepartment of Pathology, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Chieko KudoDepartment of Medical Oncology, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Munenori NagaoDepartment of Supportive Medicine and Care for Cancer, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Yojiro IshikawaDepartment of Radiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Satoshi TeramuraDepartment of Radiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Fumiaki ShinoharaDepartment of Dentistry and Oral Surgery, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.
Kazuhiro MurakamiDepartment of Pathology, Tohoku Medical and Pharmaceutical University Hospital, Sendai 983-8512, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer metastasizing to the gingiva is rare. The present study reports a case of maxillary gingival metastasis arising from gastric cancer treated with chemotherapy, surgical excision and radiotherapy. A 55-year-old male, who received chemotherapy with trifluridine/tipiracil for treatment of refractory gastric cancer with multiple metastasis, was admitted to the Department of Dentistry and Oral Surgery, Tohoku Medical and Pharmaceutical University Hospital (Sendai, Japan) in December 2023 because of the right side of the maxillary gingival mass presenting with protruding growth. The size of the tumor was ~20 mm. Tumor excision was performed followed by histopathological diagnosis which revealed a metastatic gingival tumor originating from gastric adenocarcinoma. Consequently, the patient underwent a palliative Radiation Therapy Oncology Group 8502 'QUAD shot' regimen. Although there was no progression of oral lesion, the patient died 3 months after diagnosis of gingival metastasis. The present study reviewed previous case records of gingival metastasis originating from gastric cancer and summarized treatment modalities along with clinicopathological association. In conclusion, the prognosis of patients with metastases to the oral region (MOR) is usually unfavorable. For the management of MOR, a multidisciplinary team approach is necessary to develop appropriate treatment strategies. If there are possibilities to improve prognosis or quality of life, the consideration of combination therapy with radical or palliative intent is warranted.

Indexed as

combination therapygastric cancermaxillary gingivaMORQUAD shot

Identifiers

PMID40160300
PMCPMC11948464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.